Retrospective Study of Ginaton in the Treatment of Vascular Cognitive Impairment

doi:10.3969/j.issn.1673-5765.2023.10.008

Abstract

Abstract: Objective To evaluate the effect of Ginaton on vascular cognitive impairment.
Methods A retrospective analysis was conducted on clinical and follow-up data of patients with vascular cognitive impairment from the First Affiliated Hospital, Heilongjiang University of Chinese Medicine from January 2018 to May 2020. Patients were grouped according to whether or not they received continuous Ginaton during the follow-up period, and then matched using a propensity score. After 2 years of follow-up, the MoCA and functional activities questionnaire (FAQ) scores were observed to evaluate the efficacy of Ginaton.
Results A total of 233 patients were included, 59 in the Ginaton group and 174 in the control group. Noreplacement propensity score matching was performed, 56 cases were matched in the Ginaton group and control group respectively, and there was no significant difference between the two groups at baseline. At the end of follow-up, the MoCA scores of both groups decreased (P<0.001), and the MoCA score of the Ginaton group was better than control group, with statistical difference (P=0.029) . At the same time, the FAQ score of the Ginaton group had no significant change (P=0.059), while the FAQ score of the control group had a significant increase (P<0.001) . There was no significant difference in FAQ scores between the two groups during 2-year follow-up (P=0.136) .
Conclusions Ginaton can alleviate the cognitive decline of patients with vascular cognitive impairment and maintain the ability of daily living.

Key words: Ginaton; Vascular cognitive impairment; Real world study; Propensity score matching

摘要： 目的评价金纳多改善血管性认知障碍的疗效。
方法回顾性分析黑龙江中医药大学附属第一医院2018年1月—2020年5月因血管性认知障碍住院患者的临床及随访资料。按随访期间是否连续服用金纳多进行分组，使用倾向性评分法进行匹配，观察随访2年后MoCA和功能活动问卷（functional activites questionnaire，FAQ）评分，评估金纳多的疗效。
结果共纳入233例患者，金纳多组59例，对照组174例。无放回倾向性评分匹配后，金纳多组和对照组各匹配56例，两组基线差异无统计学意义。2年随访结束时，两组MoCA评分均较治疗前降低
（P＜0.001），金纳多组MoCA评分优于对照组，差异有统计学意义（P=0.029）；金纳多组FAQ评分较治疗前无明显改变（P=0.059），对照组FAQ评分明显增高，差异有统计学意义（P＜0.001），两组2年随访FAQ评分差异无统计学意义（P=0.136）。
结论金纳多有助于缓解血管性认知障碍患者认知功能下降，维持患者日常生活能力。

关键词: 金纳多; 血管性认知障碍; 真实世界研究; 倾向评分匹配

SUN Xiaowei, JING Yunnan. Retrospective Study of Ginaton in the Treatment of Vascular Cognitive Impairment[J]. Chinese Journal of Stroke, 2023, 18(10): 1154-1159.

孙晓伟, 景允南. 金纳多治疗血管性认知障碍的回顾性研究[J]. 中国卒中杂志, 2023, 18(10): 1154-1159.

References

[1] JIA L，QUAN M，FU Y，et al. Group for the project of dementia situation in china. dementia in China：epidemiology，clinical management，and research advances[J]. Lancet Neurol，2020，19（1）：81-92.
[2] 姜敏，刘斌. 脑卒中患者认知障碍研究进展[J]. 中国康复医学杂志，2010，25（03）：289-292.
JIANG M，LIU B. Research progress of cognitive impairment in stroke patients[J]. Chinese Journal of Rehabilitation Medicine，2010，25（03）：289-292.
[3] 中国医师协会神经内科分会认知障碍专业委员会，《中国血管性认知障碍诊治指南》编写组. 2019年中国血管性认知障碍诊治指南[J]. 中华医学杂志，2019（35）：2737-2744.
Cognitive Impairment Professional Committee of Neurology Branch of Chinese Medical Doctor Association ，the Writing group of "Guidelines for the Diagnosis and Treatment of Vascular Cognitive Impairment in China". 2019 Chinese guidelines for diagnosis and treatment of vascular cognitive impairment[J]. Natl Med China，2019（35）：2737-2744.
[4] JIA J，ZHOU A，WEI C，et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese[J]. Alzheimers Dement，2014，10（4）：439-447.
[5] LIU W，WONG A，AU L，et al. Influence of amyloid-β on cognitive decline after stroke/transient ischemic attack：three-year longitudinal study[J]. Stroke，2015，46（11）：3074-3080.
[6] ANDERSON N D. State of the science on mild cognitive impairment（MCI）[J]. CNS Spectr，2019，24（1）：78-87.
[7] TCHANTCHOU F，LACOR P N，CAO Z，et al. Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common ﬁnal pathway in hippocampal neurons[J]. J Alzheimers Dis，2009，18（4）：787-798.
[8] LI W Z，WU W Y，HUANG H，et al. Protective eﬀect of bilobalide on learning and memory impairment in rats with vascular dementia[J]. Mol Med Rep，2013，8（3）：935-941.
[9] XIE H，WANG J R，YAU L F，et al. Quantitative analysis of the flavonoid glycosides and terpene trilactones in the extract of Ginkgo biloba and evaluation of their inhibitory activity towards ﬁbril formation of β-amyloid peptide[J]. Molecules，2014，19（4）：4466-4478.
[10] LIU Q，JIN Z，XU Z，et al. Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo[J]. Cell Stress Chaperones，2019，24（2）：441-452.
[11] XIANG J，YANG F，ZHU W，et al. Bilobalide inhibits inflammation and promotes the expression of Aβ degrading enzymes in astrocytes to rescue neuronal deficiency in AD models[J]. Transl Psychiatry，2021，11（1）：542.
[12] 张俊华，郑文科，张伯礼，等. 真实世界研究[J]. 世界中医药，2019，14（12）：3101-3105.
ZHANG J H，ZHENG W K，ZHANG B L，et al. Real world study[J]. World Chinese Medicine，2019，14（12）：3101-3105.
[13] 刘鸣，贺茂林. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志，2015，48（4）：246-257.
LIU M，HE M L. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2014[J]. Chin J Neurol，2015，48（4）：246-257.
[14] 张苏明，许予明，朱遂强. 中国脑出血诊治指南（2014）[J]. 中华神经科杂志，2015，48（6）：435-444.
ZHANG S M，XU Y M，ZHU S Q. Chinese guidelines for diagnosis and treatment of cerebral hemorrhage（2014）[J]. Chin J Neurol，2015，48（6）：435-444.
[15] 贾建平. 血管性认知障碍诊治指南[J]. 中华神经科杂志，2011，（2）：142-147.
JIA J P. Guidelines for the diagnosis and treatment of vascular cognitive impairment[J]. Chin J Neurol，2011，（2）：142-147.
[16] PINTO T，MACHADO L，BULGACOV T，et al.
Is the Montreal cognitive assessment（MoCA）screeningsuper ior to the mini-mental state examination（MMSE）in the detection of mild cognitive impairment（MCI）and Alzheimer's disease（AD）in the elderly?[J]. Int Psychogeriatr，2019，31（4）：491-504.
[17] VAN DER FLIER W M，SKOOG I，SCHNEIDER J A，et al. Vascular cognitive impairment[J/OL]. Nat Rev Dis Primers，2018，4：18003[2023-03-15]. https://doi.org/10.1038/nrdp.2018.3.
[18] 徐振伟，刘晓蕾，李新毅. 银杏叶提取物治疗血管性痴呆的作用机制研究进展[J]. 中国医药，2020，17（4）：623-626.
XU Z W，LIU X L，LI X Y. Advances in therapeutic mechanisms of Ginkgo biloba extract against vascular dementia[J]. China Medicine，2020，17（4）：623-626.
[19] 秦雪妮，陈维生，邵华，等. 真实世界研究在医药领域的应用及研究方法[J]. 药学进展，2021，45（7）：512-523.
QIN X N，CHEN W S，SHAO H，et al. Application and research method of real world research in the medical field[J]. Progress in Pharmaceutical Sciences，2021，45（7）：512-523.
[20] HAUKOOS J S，LEWIS R J. The propensity score[J]. JAMA，2015，314（15）：1637-1638.
[21] SINGH S K，SRIVASTAV S，CASTELLANI R J，et al. Neuroprotective and antioxidant eﬀect of Ginkgo biloba extract against AD and other neurological disorders[J]. Neuro therapeutics，2019，16（3）：666-674.
[22] LI M Y，CHANG C T，HAN Y T，et al. Ginkgolide B promotes neuronal differentiation through the Wnt/β-catenin pathway in neural stem cells of the postnatal mammalian subventricular zone[J/OL]. Sci Rep，2018，8（1）：14947[2023-01-15]. https://doi.org/10.1038/s41598-018-32960-8.
[23] 孙微，王一帆，张佳月. 金纳多对血管性痴呆大鼠认知功能、海马区细胞凋亡及炎性因子的影响[J]. 中国老年学杂志，2021，41（16）：3532-3535.
SUN W，WANG Y F，ZHANG J Y. Effects of Ginaton on cognitive function，hippocampal cell apoptosis and inflammatory factors in rats with vascular dementia[J]. Chinese Journal of Gerontology，2021，41（16）：3532-3535.
[24] 徐睿，王雪鹏，周兵. 银杏叶提取物对血管性痴呆大鼠记忆力及GAT1、CREB表达的影响[J]. 中国实验诊断学，2020，24（2）：295-298.
XU R，WANG X P，ZHOU B. Effects of Ginkgo biloba extract on memory and expression of GATI and CREB in rats with vascular dementia[J]. Chin J Lab Diagn，2020，24（2）：295-298.
[25] 王淑英，王为光，高占群，等. 银杏叶提取物对大鼠局灶性脑缺血再灌注组织中缺氧诱导因子-1α表达的影响[J]. 中国老年学杂志，2020，40（14）：3088-3090.
WANG S Y，WANG W G，GAO Z Q，et al. Effect of Ginkgo biloba extract on the expression of hypoxia-inducible factor-1α in focal cerebral ischemia-reperfusion in rats[J]. Chinese Journal of Gerontology，2020，40（14）：3088-3090.
[26] GARGOURI B，CARSTENSEN J，BHATIA H S，et al. Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells[J]. Phytomedicine，2018（44）：45-55.
[27] DOGAN R，SJOSTRAND A P，YENıGUN A，et al. Inﬂuence of Ginkgo Biloba extract（eGb 761）on expression of IL-1β，Il-6，TNF-α，HSP-70，HSF-1 and COX-2 after noise exposure in the rat cochlea[J]. Auris Nasus Larynx，2018，45（4）：680-685.
[28] 刘进，周杰，李王文，等. 不同剂量银杏叶提取物对血管性认知功能障碍大鼠认知功能和神经递质水平的影响[J]. 疑难病杂志，2021，20（2）：182-186.
LIU J，ZHOU J，LI W W，et al. Effects of different doses of Ginkgo biloba extract on cognitive function and neurotransmitter level in rats with vascular cognitive impairment[J]. Chin J Diffic and Compl Cas，2021，20（2）：182-186.
[29] WHISSELL P D，BANG J Y，KHAN I，et al. Selective activation of cholecystokinin-expressing GABA（CCK-GABA）neurons enhances memory and cognition[J/OL]. eNeuro，2019，6（1）：e0360[2023-03-15]. https://doi.org/10.1523/ENEURO.0360-18.2019.
[30] 徐悦，邓超，郑永强. 银杏叶提取物对脑缺血再灌注损伤大鼠血脑屏障的保护作用及ROCK、MLCK、 MMP-2表达的影响[J]. 四川中医，2019，37（7）：44-48.
XU Y，DENG C，ZHENG Y Q. Protective Effects of Ginkgo Biloba Extract on Blood Brain Barrier and Expression of ROCK，MLCK and MMP-2 in Rats with Cerebral Ischemia-Reperfusion Injury[J]. Journal of Sichuan of Traditional Chinese Medicine，2019，37（7）：44-48.